Growth Metrics

Healthstream (HSTM) EPS (Weighted Average and Diluted) (2016 - 2026)

Healthstream has reported EPS (Weighted Average and Diluted) over the past 16 years, most recently at $0.09 for Q4 2025.

  • Quarterly EPS (Weighted Average and Diluted) fell 43.75% to $0.09 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $0.61 through Dec 2025, down 7.58% year-over-year, with the annual reading at $0.61 for FY2025, 7.58% down from the prior year.
  • EPS (Weighted Average and Diluted) was $0.09 for Q4 2025 at Healthstream, down from $0.2 in the prior quarter.
  • Over five years, EPS (Weighted Average and Diluted) peaked at $0.2 in Q3 2025 and troughed at -$0.02 in Q4 2021.
  • The 5-year median for EPS (Weighted Average and Diluted) is $0.12 (2022), against an average of $0.12.
  • Year-over-year, EPS (Weighted Average and Diluted) plummeted 166.67% in 2021 and then soared 500.0% in 2022.
  • A 5-year view of EPS (Weighted Average and Diluted) shows it stood at -$0.02 in 2021, then soared by 500.0% to $0.08 in 2022, then skyrocketed by 87.5% to $0.15 in 2023, then rose by 6.67% to $0.16 in 2024, then tumbled by 43.75% to $0.09 in 2025.
  • Per Business Quant, the three most recent readings for HSTM's EPS (Weighted Average and Diluted) are $0.09 (Q4 2025), $0.2 (Q3 2025), and $0.18 (Q2 2025).